Literature DB >> 15520614

Role of norepinephrine in the pathophysiology of neuropsychiatric disorders.

K J Ressler1, C B Nemeroff.   

Abstract

The concatenation of convergent lines of evidence from basic to clinical research continues to reveal that norepinephrine (NE) is a crucial regulator of a myriad of behaviors ranging from stress response to memory formation. Furthermore, many neuropsychiatric disorders involve neurocircuitry that is directly modulated by NE. This report summarizes the physiological roles of NE, as well as the main findings implicating a role for NE system dysfunction in mood and anxiety disorders, posttraumatic stress disorder, attention-deficit/hyperactivity disorder, and Alzheimer's disease. In each of these disorders, there appears to be a complex dysregulation of NE function, with changes in locus ceruleus firing, NE availability, and both pre- and postsynaptic receptor regulation. Many symptoms of these disorders are attributable to abnormalities within distributed neural circuits regulated by NE. Appreciation of NE's role in modulating the neural circuitry mediating cognition and affect should help elucidate the pathophysiology of a variety of neuropsychiatric disorders and the development of novel treatments.

Entities:  

Year:  2001        PMID: 15520614     DOI: 10.1017/s1092852900001358

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  11 in total

1.  Adolescent social isolation increases anxiety-like behavior and ethanol intake and impairs fear extinction in adulthood: Possible role of disrupted noradrenergic signaling.

Authors:  M J Skelly; A E Chappell; E Carter; J L Weiner
Journal:  Neuropharmacology       Date:  2015-06-01       Impact factor: 5.250

2.  Neuroanatomical targets of reboxetine and bupropion as revealed by pharmacological magnetic resonance imaging.

Authors:  Sakthivel Sekar; J Van Audekerke; G Vanhoutte; A S Lowe; A M Blamire; A Van der Linden; T Steckler; M Shoaib; Marleen Verhoye
Journal:  Psychopharmacology (Berl)       Date:  2011-05-07       Impact factor: 4.530

Review 3.  A locus coeruleus-norepinephrine account of individual differences in working memory capacity and attention control.

Authors:  Nash Unsworth; Matthew K Robison
Journal:  Psychon Bull Rev       Date:  2017-08

4.  The Addition of Amphetamine to Potentially Sedating Medication Regimens: An Exploratory Investigation of the Impact upon Reaction Time and Sustained Attention.

Authors:  James W Price
Journal:  Psychopharmacol Bull       Date:  2017-05-15

5.  Neurocognitive function in dopamine-β-hydroxylase deficiency.

Authors:  Marieke Jepma; Jaap Deinum; Christopher L Asplund; Serge Arb Rombouts; Jouke T Tamsma; Nathanja Tjeerdema; Michiel M Spapé; Emily M Garland; David Robertson; Jacques Wm Lenders; Sander Nieuwenhuis
Journal:  Neuropsychopharmacology       Date:  2011-04-06       Impact factor: 7.853

6.  Modulation of Drosophila male behavioral choice.

Authors:  Sarah J Certel; Mary Grace Savella; Dana C F Schlegel; Edward A Kravitz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

7.  Long-term administration of citalopram reduces basal and stress-induced extracellular noradrenaline levels in rat brain.

Authors:  Yukie Kawahara; Hiroshi Kawahara; Fumi Kaneko; Masatoshi Tanaka
Journal:  Psychopharmacology (Berl)       Date:  2007-05-30       Impact factor: 4.530

8.  Major depressive disorder and alterations in insular cortical activity: a review of current functional magnetic imaging research.

Authors:  Diane Sliz; Shawn Hayley
Journal:  Front Hum Neurosci       Date:  2012-12-03       Impact factor: 3.169

9.  The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity.

Authors:  T N Wise; C G Wiltse; D V Iosifescu; M Sheridan; J Y Xu; J Raskin
Journal:  Int J Clin Pract       Date:  2007-06-22       Impact factor: 2.503

10.  Chronic treatment with prazosin or duloxetine lessens concurrent anxiety-like behavior and alcohol intake: evidence of disrupted noradrenergic signaling in anxiety-related alcohol use.

Authors:  Mary J Skelly; Jeff L Weiner
Journal:  Brain Behav       Date:  2014-04-14       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.